2.要約四半期連結財務諸表及び主な注記
(1)要約四半期連結純損益及びその他の包括利益計算書
| | (単位:百万円) |
| 前第3四半期連結累計期間 (自 2023年4月1日 至 2023年12月31日) | 当第3四半期連結累計期間 (自 2024年4月1日 至 2024年12月31日) |
売上収益 | 222,833 | 222,773 |
売上原価 | △91,600 | △97,642 |
売上総利益 | 131,233 | 125,130 |
販売費及び一般管理費 | △64,749 | △64,702 |
研究開発費 | △18,208 | △16,773 |
製品に係る無形資産償却費 | △7,083 | △6,638 |
その他の収益 | 1,366 | 384 |
その他の費用 | △6,401 | △2,206 |
営業利益 | 36,157 | 35,195 |
金融収益 | 1,313 | 1,429 |
金融費用 | △981 | △1,316 |
持分法による投資損失 | △2,930 | - |
税引前四半期利益 | 33,559 | 35,309 |
法人所得税費用 | △6,979 | △7,961 |
四半期利益 | 26,580 | 27,348 |
その他の包括利益 | | |
純損益に振り替えられない項目: | | |
その他の包括利益を通じて公正価値で測定する金融資産の純変動 | △577 | △2,221 |
純損益に振り替えられる可能性のある項目: | | |
在外営業活動体の換算差額 | 6,341 | 1,928 |
キャッシュ・フロー・ヘッジ | △29 | 15 |
持分法適用会社におけるその他の包括利益に対する持分 | 635 | 115 |
その他の包括利益 | 6,369 | △163 |
四半期包括利益合計 | 32,948 | 27,185 |
四半期利益の帰属 | | |
親会社の所有者持分 | 26,613 | 27,465 |
非支配持分 | △33 | △117 |
四半期利益 | 26,580 | 27,348 |
四半期包括利益合計の帰属 | | |
親会社の所有者持分 | 33,002 | 27,318 |
非支配持分 | △53 | △132 |
四半期包括利益合計 | 32,948 | 27,185 |
1株当たり四半期利益 | | |
基本的1株当たり四半期利益(円) | 72.26 | 78.21 |
希薄化後1株当たり四半期利益(円) | 72.05 | 77.98 |
<コアベース>
売上収益 | 222,833 | 222,773 |
コア営業利益 | 49,288 | 43,655 |
コア四半期利益 | 39,604 | 33,785 |
基本的1株当たりコア四半期利益(円) | 107.61 | 96.30 |
希薄化後1株当たりコア四半期利益(円) | 107.29 | 96.02 |
コア四半期利益の帰属 | | |
親会社の所有者持分 | 39,629 | 33,817 |
非支配持分 | △25 | △31 |
コア四半期利益 | 39,604 | 33,785 |
E0094945360参天製薬株式会社SANTEN PHARMACEUTICAL CO., LTD.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2024-04-012024-12-31Q32025-03-312023-04-012023-12-312024-03-311falsefalsefalse453602024-04-012024-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-04-012024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602024-04-012024-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602023-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602023-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602023-12-31jpigp_cor:RetainedEarningsIFRSMember453602023-12-31jpigp_cor:TreasurySharesIFRSMember453602023-12-31jpigp_cor:CapitalSurplusIFRSMember453602023-12-31jpigp_cor:ShareCapitalIFRSMember453602024-04-012024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602023-04-012023-12-31jpigp_cor:NonControllingInterestsIFRSMember453602023-04-012023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602023-04-012023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602023-04-012023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602023-04-012023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602023-04-012023-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602023-04-012023-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602023-04-012023-12-31jpigp_cor:RetainedEarningsIFRSMember453602023-04-012023-12-31jpigp_cor:TreasurySharesIFRSMember453602023-04-012023-12-31jpigp_cor:CapitalSurplusIFRSMember453602023-04-012023-12-31jpigp_cor:ShareCapitalIFRSMember453602023-03-31jpigp_cor:NonControllingInterestsIFRSMember453602023-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602023-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602023-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602023-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602023-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602023-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602023-03-31jpigp_cor:RetainedEarningsIFRSMember453602023-03-31jpigp_cor:TreasurySharesIFRSMember453602023-03-31jpigp_cor:CapitalSurplusIFRSMember453602023-03-31jpigp_cor:ShareCapitalIFRSMember453602024-12-31jpigp_cor:NonControllingInterestsIFRSMember453602024-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602024-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602024-12-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-12-31jpigp_cor:RetainedEarningsIFRSMember453602024-12-31jpigp_cor:TreasurySharesIFRSMember453602024-12-31jpigp_cor:CapitalSurplusIFRSMember453602024-12-31jpigp_cor:ShareCapitalIFRSMember453602024-04-012024-12-31jpigp_cor:NonControllingInterestsIFRSMember453602024-04-012024-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-03-31jpigp_cor:NonControllingInterestsIFRSMember453602024-04-012024-12-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-04-012024-12-31jpigp_cor:RetainedEarningsIFRSMember453602024-04-012024-12-31jpigp_cor:TreasurySharesIFRSMember453602024-04-012024-12-31jpigp_cor:CapitalSurplusIFRSMember453602024-04-012024-12-31jpigp_cor:ShareCapitalIFRSMember453602024-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602024-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602024-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602024-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember453602024-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember453602024-03-31jpigp_cor:RetainedEarningsIFRSMember453602024-03-31jpigp_cor:TreasurySharesIFRSMember453602024-03-31jpigp_cor:CapitalSurplusIFRSMember453602024-03-31jpigp_cor:ShareCapitalIFRSMember453602023-12-31jpigp_cor:NonControllingInterestsIFRSMember453602023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember453602023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember453602023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember453602024-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember453602024-12-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602024-04-012024-12-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602024-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602023-12-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602023-04-012023-12-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602023-03-31jpigp_cor:ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember453602025-02-06453602024-12-31453602024-04-012024-12-31453602023-12-31453602023-04-012023-12-31453602024-03-31453602023-03-31453602024-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602024-04-012024-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602023-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602023-04-012023-12-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602024-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember453602023-03-31jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure